3 line items for zonisamide capsules. Award for a base year of 6/15/2026 - to 6/14/2027 plus four one-year option periods.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79726D0021
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 34% complete
IDV ceiling
$4,242,730.10
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for Zonisamide capsules with a ceiling of $4,242,730.10 on June 15, 2026. The contract runs for a base year from June 15, 2026 to June 14, 2027, with four one-year option periods. No set-aside applies.

Performance occurs at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and other designated federal delivery locations as specified by the VA and other customer agencies.

The originating solicitation (RFP 36E79726R0005) sought a single contractor to supply Zonisamide capsules for multiple federal agencies—the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers—in commercial item format under FAR Part 12. Estimated annual requirements total approximately 41,351 bottles of 100mg capsules, 4,539 bottles of 25mg capsules, and 5,326 bottles of 50mg capsules. The contract requires an uninterrupted source of supply and maintenance of product integrity with unique NDC-labeled packaging.

The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing); PSC code is 6505 (Drugs and Biologicals). A modification incorporated Section 5 of Executive Order 14398 into the contract terms.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Modification to incorporate section 5 of executive order (EO) 14398. $0
Add Subcontract Plan P00001 · Incorporate 2026/2027 subk plan $0
Original award $0

Quick answers

Who was awarded contract 36E79726D0021?

36E79726D0021 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on June 15, 2026.

How much is contract 36E79726D0021 worth?

36E79726D0021's own ceiling is $4,242,730.

Who can order from contract 36E79726D0021?

36E79726D0021 is a single award indefinite delivery contract.

Was contract 36E79726D0021 competed?

The extent of competition for 36E79726D0021 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV